Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial".
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial".